Synthesis and characterization of azole isoflavone inhibitors of aromatase. 2005

John C Hackett, and Young-Woo Kim, and Bin Su, and Robert W Brueggemeier
Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, 500 W. 12th Avenue, Columbus, OH 43210, USA.

The synthesis and biological evaluation of a series of 2-azole and 2-thioazole isoflavones as potential aromatase inhibitors are described. Differences in inhibitory activity of triazole and imidazole inhibitors are rationalized with density functional theory to expose a key difference in the electronic structure of these molecules. In addition, difference binding spectra of inhibitors to immunoaffinity-purified aromatase produces classical Type II spectra consistent with coordination of the nitrogen lone pair electrons to the aromatase P450 heme.

UI MeSH Term Description Entries
D007529 Isoflavones 3-Phenylchromones. Isomeric form of FLAVONOIDS in which the benzene group is attached to the 3 position of the benzopyran ring instead of the 2 position. 3-Benzylchroman-4-One,3-Benzylidene-4-Chromanone,Homoisoflavone,Homoisoflavones,Isoflavone,Isoflavone Derivative,3-Benzylchroman-4-Ones,3-Benzylidene-4-Chromanones,Isoflavone Derivatives,3 Benzylchroman 4 One,3 Benzylchroman 4 Ones,3 Benzylidene 4 Chromanone,3 Benzylidene 4 Chromanones,Derivative, Isoflavone,Derivatives, Isoflavone
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008861 Microsomes Artifactual vesicles formed from the endoplasmic reticulum when cells are disrupted. They are isolated by differential centrifugation and are composed of three structural features: rough vesicles, smooth vesicles, and ribosomes. Numerous enzyme activities are associated with the microsomal fraction. (Glick, Glossary of Biochemistry and Molecular Biology, 1990; from Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed) Microsome
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D010920 Placenta A highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products. It includes a fetal portion (CHORIONIC VILLI) derived from TROPHOBLASTS and a maternal portion (DECIDUA) derived from the uterine ENDOMETRIUM. The placenta produces an array of steroid, protein and peptide hormones (PLACENTAL HORMONES). Placentoma, Normal,Placentome,Placentas,Placentomes
D004583 Electrons Stable elementary particles having the smallest known negative charge, present in all elements; also called negatrons. Positively charged electrons are called positrons. The numbers, energies and arrangement of electrons around atomic nuclei determine the chemical identities of elements. Beams of electrons are called CATHODE RAYS. Fast Electrons,Negatrons,Positrons,Electron,Electron, Fast,Electrons, Fast,Fast Electron,Negatron,Positron
D005260 Female Females
D006418 Heme The color-furnishing portion of hemoglobin. It is found free in tissues and as the prosthetic group in many hemeproteins. Ferroprotoporphyrin,Protoheme,Haem,Heme b,Protoheme IX
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000735 Androstenedione A delta-4 C19 steroid that is produced not only in the TESTIS, but also in the OVARY and the ADRENAL CORTEX. Depending on the tissue type, androstenedione can serve as a precursor to TESTOSTERONE as well as ESTRONE and ESTRADIOL. 4-Androstene-3,17-dione,delta-4-Androstenedione,4 Androstene 3,17 dione,delta 4 Androstenedione

Related Publications

John C Hackett, and Young-Woo Kim, and Bin Su, and Robert W Brueggemeier
May 1993, Journal of medicinal chemistry,
John C Hackett, and Young-Woo Kim, and Bin Su, and Robert W Brueggemeier
May 2020, ACS medicinal chemistry letters,
John C Hackett, and Young-Woo Kim, and Bin Su, and Robert W Brueggemeier
January 2018, Anti-cancer agents in medicinal chemistry,
John C Hackett, and Young-Woo Kim, and Bin Su, and Robert W Brueggemeier
March 1990, Steroids,
John C Hackett, and Young-Woo Kim, and Bin Su, and Robert W Brueggemeier
November 2006, Annals of the New York Academy of Sciences,
John C Hackett, and Young-Woo Kim, and Bin Su, and Robert W Brueggemeier
July 2016, Bioorganic & medicinal chemistry letters,
John C Hackett, and Young-Woo Kim, and Bin Su, and Robert W Brueggemeier
January 2001, Breast cancer (Tokyo, Japan),
John C Hackett, and Young-Woo Kim, and Bin Su, and Robert W Brueggemeier
November 2017, Tetrahedron letters,
John C Hackett, and Young-Woo Kim, and Bin Su, and Robert W Brueggemeier
March 2015, Journal of fluorescence,
John C Hackett, and Young-Woo Kim, and Bin Su, and Robert W Brueggemeier
June 1985, Journal of medicinal chemistry,
Copied contents to your clipboard!